[an error occurred while processing this directive]
中华放射肿瘤学杂志
   2025年4月7日 星期一     首 页 |  期刊介绍  |  编 委 会  |  投稿指南  |  期刊订阅  |  广告合作  |  学术影响  |  收录情况  |  联系我们  |  English
中华放射肿瘤学杂志  2023, Vol. 32 Issue (2): 93-98    DOI: 10.3760/cma.j.cn113030-20220207-00051
调查研究 最新目录| 下期目录| 过刊浏览| 高级检索 [an error occurred while processing this directive]|[an error occurred while processing this directive]
局限期小细胞肺癌放射治疗决策的现况调查
徐畅1, 李萌2, 陈明3, 祝淑钗4, 毕楠5, 蔡旭伟6, 袁双虎7, 曹建忠8, 胡晓9, 李建成10, 周伟11, 王平1, 王军2, 赵路军1, 刘宁波1
1天津医科大学肿瘤医院放疗科,国家肿瘤临床医学研究中心天津市“肿瘤防治”重点实验室,天津市恶性肿瘤临床医学研究中心,天津 300060;
2天津市肿瘤医院空港医院放疗科,天津 300308;
3中山大学肿瘤防治中心放疗科,华南肿瘤学国家重点实验室,肿瘤医学省部共建协同创新中心,广州 510055;
4河北医科大学第四医院放疗科,石家庄 050011;
5国家癌症中心/国家肿瘤临床医学研究中心/中国医学科学院北京协和医学院肿瘤医院放疗科,北京 100021;
6上海市胸科医院放疗科,上海 200030;
7山东省肿瘤医院放疗科,济南 250117;
8山西省肿瘤医院放疗科,太原 030013;
9浙江省肿瘤医院放疗科,杭州 310005;
10福建省肿瘤医院放疗科,福州 350014;
11重庆大学附属肿瘤医院放疗科,重庆 400030
Radiation dose and fractionation regimen for limited stage small cell lung cancer: a survey of current practice patterns of Chinese radiation oncologists
Xu Chang1, Li Meng2, Chen Ming3, Zhu Shuchai4, Bi Nan5, Cai Xuwei6, Yuan Shuanghu7, Cao Jianzhong8, Hu Xiao9, Li Jiancheng10, Zhou Wei11, Wang Ping1, Wang Jun2, Zhao Lujun1, Liu Ningbo1
1Department of Radiation Oncology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, Tianjin's Clinical Research Center for Cancer, Tianjin 300060, China;
2Department of Radiation Oncology, Konggang Branch of Tianjin Cancer Hospital, Tianjin 300308, China;
3Department of Radiation Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou 510055, China;
4Department of Radiation Oncology, the Fourth Hospital of Hebei Medical University, Shijiazhuang 050011, China;
5Department of Radiation Oncology, National Cancer Center / National Clinical Research Center for Cancer/ Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China;
6Department of Radiation Oncology, Shanghai Chest Hospital, Shang Hai 200030, China;
7Department of Radiation Oncology, Shandong Cancer Hospital, Ji'nan 250117, China;
8Department of Radiation Oncology, Shanxi Provincial Cancer Hospital, Taiyuan 030013, China;
9Department of Radiation Oncology, Zhejiang Cancer Hospital, Hangzhou 310005, China;
10Department of Radiation Oncology, Fujian Cancer Hospital, Fuzhou 350014, China;
11Department of Radiation Oncology, Chongqing University Cancer Hospital, Chongqing 400030, China
全文: PDF (0 KB)   HTML (1 KB) 
输出: BibTeX | EndNote (RIS)      背景资料
摘要 目的 调查中国放射肿瘤医生在局限期小细胞肺癌放疗中分割方案及剂量的选择情况。方法 对超过500名放射肿瘤医生进行关于局限期小细胞肺癌放疗推荐及实际中分割方式及相关剂量的选择等问题的问卷调查,获得可用结果216份,并对可用结果进行分析。所有数据通过问卷星软件制作的在线问卷收集,使用SPSS 25.0软件进行数据整理和统计学分析。Fisher精确检验以及χ2检验用于比较分类变量之间的组间差异。结果 216名医生中,94.9%推荐早期同步放化疗,69.4%推荐常规分割方案,70.8%推荐60 Gy作为常规分割方案的总剂量,78.7%推荐45 Gy作为超分割方案的总剂量。结论 尽管实际工作中对分割方式和剂量的选择存在差异,目前大多数中国放射肿瘤医生在临床实践中更倾向于选择60 Gy常规分割方案。中国临床肿瘤学会(CSCO)、美国国家综合癌症网(NCCN)及中华医学会等的指南或专家共识对日常治疗决策起着重要的指导作用。
服务
把本文推荐给朋友
加入我的书架
加入引用管理器
E-mail Alert
RSS
作者相关文章
徐畅
李萌
陈明
祝淑钗
毕楠
蔡旭伟
袁双虎
曹建忠
胡晓
李建成
周伟
王平
王军
赵路军
刘宁波
关键词 小细胞肺癌局限期放射疗法胸部超分割大分割    
AbstractObjective To investigate the radiation dose and fractionation regimens for limited stage small cell lung cancer (LS-SCLC) in Chinese radiation oncologists. Methods Over 500 radiation oncologists were surveyed through questionnaire for radiation dose and fractionation regimens for LS-SCLC and 216 valid samples were collected for further analysis. All data were collected by online questionnaire designed by WJX software. Data collection and statistical analysis were performed by SPSS 25.0 statistical software. The differences in categorical variables among different groups were analyzed by Chi-square test and Fisher's exact test. Results Among 216 participants, 94.9% preferred early concurrent chemoradiotherapy, 69.4% recommended conventional fractionation, 70.8% preferred a total dose of 60 Gy when delivering conventional radiotherapy and 78.7% recommended 45 Gy when administering hyperfractionated radiotherapy. Conclusions Despite differences in LS-SCLC treatment plans, most of Chinese radiation oncologists prefer to choose 60 Gy conventional fractionated radiotherapy as the main treatment strategy for LS-SCLC patients. Chinese Society of Clinical Oncology (CSCO), National Comprehensive Cancer Network (NCCN) and Chinese Medical Association guidelines or expert consensus play a critical role in guiding treatment decision-making.
Key wordsSmall cell lung carcinoma    limited stage    Radiography    thoracic    Hyper-fractionation    Hypo-fractionation   
收稿日期: 2022-02-07     
通讯作者: 刘宁波,Email:liuningbo@tjmuch.com;赵路军,Email:zhaolujun@tjmuch.com   
引用本文:   
徐畅,李萌,陈明等. 局限期小细胞肺癌放射治疗决策的现况调查[J]. 中华放射肿瘤学杂志, 2023, 32(2): 93-98.
Xu Chang,Li Meng,Chen Ming et al. Radiation dose and fractionation regimen for limited stage small cell lung cancer: a survey of current practice patterns of Chinese radiation oncologists[J]. Chinese Journal of Radiation Oncology, 2023, 32(2): 93-98.
链接本文:  
http://journal12.magtechjournal.com/Jweb_fszlx/CN/10.3760/cma.j.cn113030-20220207-00051     或     http://journal12.magtechjournal.com/Jweb_fszlx/CN/Y2023/V32/I2/93
京公网安备11010502022167号
版权所有 © 2010《中华放射肿瘤学杂志》编辑部
地址:北京朝阳区潘学园南里17号 中国医学科学院肿瘤医院(100021)
电话:010-67700737,87788294 Email: cjron@cmaph.org
本系统由北京玛格泰克科技发展有限公司设计开发 技术支持:Support@magtech.com.cn